Helicobacter pylori infection reduces the efficacy of cancer immunotherapy: A systematic review and meta‐analysis

Helicobacter pylori infection reduces the efficacy of cancer immunotherapy: A systematic review and meta‐analysis
复制标题

DOI：
10.1111/hel.13011
复制
发表时间：
2023-09
期刊：
Helicobacter
影响因子：
4.4
通讯作者：
Xiao-ling Gong;Liting Shen;Jinliang Xie;Dingwei Liu;Yong Xie;Dong-sheng Liu
Xiao-ling Gong;Liting Shen;Jinliang Xie;Dingwei Liu;Yong Xie;Dong-sheng Liu
中科院分区：
医学2区
文献类型：
--
作者：
Xiao-ling Gong;Liting Shen;Jinliang Xie;Dingwei Liu;Yong Xie;Dong-sheng Liu

文献摘要

相似文献

Cancer immunotherapy has shown promising results in several tumors, but its efficacy is influenced by the immune state of the body. Helicobacter pylori (H. pylori) infection can modulate the immune function of the body through various pathways, ultimately affecting the effectiveness of cancer immunotherapy.